Germany s Vaccination Campaign: The Race for Herd Immunity spiegel.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from spiegel.de Daily Mail and Mail on Sunday newspapers.
Germany s health ministry on Wednesday downplayed the possible impact on the country s coronavirus vaccine campaign after reports that the shot being developed by local company CureVac could face further delays getting regulatory approval.
BERLIN
Germany’s health ministry on Wednesday downplayed the possible impact on the country’s coronavirus vaccine campaign after reports that the shot being developed by local company CureVac could face further delays getting regulatory approval.
Manfred Lucha, the health minister for Baden-Wuerttemberg state, where CureVac is based, said Tuesday that there were “complications” with CureVac’s clinical trials, German news agency dpa reported. Lucha quoted federal Health Minister Jens Spahn saying authorization for the shot might not happen before August.
Spahn’s spokesman, Hanno Kautz, declined to comment on the report, saying the conversation cited by Lucha was confidential.
South Africa halts J&J vaccine jabs; Europe rollout delayed mainichi.jp - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mainichi.jp Daily Mail and Mail on Sunday newspapers.
J&J delays vaccine rollout in Europe amid clot fears in US
Business Related
Yes
Boxes of Janssen vaccines sit at a warehouse of Hungaropharma, a Hungarian pharmaceutical wholesale company, in Budapest, Hungary, after the arrival of the first batch of the Johnson & Johnson, US, made one-dose vaccine against the new coronavirus in the country Tuesday, April 13, 2021. The first shopment contains 28 thousand doses of Janssen. (Szilard Koszticsak/MTI via AP)
BERLIN – Johnson & Johnson said Tuesday it is delaying the rollout of its coronavirus vaccine in Europe amid a U.S. probe into reports of rare blood clots in some recipients, moves that experts worry could further shake vaccine confidence and complicate COVID-19 immunization efforts.